The Norwegian Multiple Sclerosis Registry and Biobank

Acta Neurologica Scandinavica

Volumn 126, Issue S195, 2012, Pages 20-23

  Myhr, K M ^a,b   Grytten, N ^a   Aarseth, J H ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Biobank; Diagnosis; Multiple Sclerosis; Quality control; Registry; Treatment

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; DATA COLLECTION METHOD; DISEASE REGISTRY; HUMAN; INFORMED CONSENT; MULTIPLE SCLEROSIS; HEALTH CARE FACILITY; INFORMATION PROCESSING; MENTAL CAPACITY; NORWAY; REGISTER;

BIOLOGICAL SPECIMEN BANKS; DATA COLLECTION; HUMANS; INFORMED CONSENT; MENTAL COMPETENCY; MULTIPLE SCLEROSIS; NORWAY; REGISTRIES;

EID: 84883475729     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12030     Document Type: Article

References (34)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17.
2. Myhr KM, Riise T, Vedeler C, et al. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Scler 2001;7:59-65.
3. Grytten T, Lie SA, Aarseth JH, Nyland H, Myhr KM. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway. Mult Scler 2008;14:1191-8.
4. Svendsen B, Myhr KM, Nyland H, Aarseth JH. The cost of multiple sclerosis in Norway. Eur J Health Econ 2012;13:81-91.
5. Myhr KM. Diagnosis and treatment of multiple sclerosis. Acta Neurol Scand Suppl 2008;188:12-21.
6. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
7. Myhr KM, Mellgren SI. Corticosteroids in the treatment of multiple sclerosis. Acta Neurol Scand Suppl 2009;189:73-80.
8. Myhr KM. Pharmacological treatment of multiple sclerosis. Tidsskr Nor Laegeforen 2010;130:490-2.
9. Harbo HF, Mørk S, Vedeler C, Myhr KM. Multiple sclerosis biobank established. Tidsskr Nor Laegeforen 2007;127:2276.
10. Myhr KM, Grytten N, Aarseth JH, Nyland H. The Norwegian Multiple Sclerosis National Competence Centre and National Multiple Sclerosis registry - a resource for clinical practice and research. Acta Neurol Scand Suppl 2006;183:37-40.
11. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
12. Fischer JS, Jack AJ, Knicker JE, et al. Administration and scoring manual for the multiple sclerosis functional composite measure (MSFC). New York: Demos Medical Publishing, Inc., 1999.
13. Smith A. Symbol digit modalities test: manual. Los Angeles, CA: Western Psychological Services, 1982.
14. Krupp LB, Larocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
15. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001;124:962-73.
16. Rabin R, De C. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001l;33:337-43.
17. Dahl J, Myhr KM, Daltveit AK, Gilhus NE. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol 2008;255:623-7.
18. Riise T, Kirkeleit J, Aarseth JH, et al. Risk of MS is not associated with exposure to crude oil, but increases with low level of education. Mult Scler 2011;17:780-7.
19. Midgard R. Incidence and prevalence of multiple sclerosis in Norway. Acta Neurol Scand 2012;126(Suppl. 195):36-42.
20. Pugliatti M, Casetta I, Drulovic J, et al. A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q). Acta Neurol Scand 2012;126(Suppl. 195):43-50.
21. Lorentzen AR, Melum E, Ellinghaus E, et al. Association to the Glypican-5 gene in multiple sclerosis. J Neuroimmunol 2010;226:194-7.
22. Mero IL, Ban M, Lorentzen ÅR, et al. Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus. Genes Immun 2011;12:191-8.
23. The International Multiple Sclerosis Genetics Consortium (IMSGC), Wellcome Trust Case Control Consortium 2 (WTCCC2). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214-9.
24. Harbo HF, Meri IL. From genes to characteristics of multiple sclerosis. Acta Neurol Scand 2012;126(Suppl. 195):58-62.
25. Grytten N, J.Aarseth H, Espeset K, et al. Health related quality of life and disease modifying treatment behaviour in relapsing- remitting multiple sclerosis - a multicentre cohort study. Acta Neurol Scand 2012;126(Suppl. 195):51-57.
26. Torkildsen Ø, Grytten N, Aarseth JH, Myhr K-M, Kampman MT. Month of birth as a risk factor for multiple sclerosis: an update. Acta Neurol Scand 2012;126(Suppl. 195):57-61.
27. Holmøy T, Torkildsen Ø, Myhr K-M, Løken KI. Vitamin D supplementation and monitoring in MS: who, when, and wherefore. Acta Neurol Scand 2012;126(Suppl. 195):63-69.
28. Wergeland S, Torkildsen Ø, Bø L, Myhr K-M. Polyunsaturated fatty acids in multiple sclerosis therapy. Acta Neurol Scand 2012;126(Suppl. 195):70-75.
29. Kroksveen AC, Guldbrandsen A, Vedeler C, Myhr KM, Opsahl JA, Berven FS. Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls. Acta Neurol Scand 2012;126(Suppl. 195):90-96.
30. Torkildsen Ø, Grytten N, Myhr KM. Immunomodulatory treatment of multiple sclerosis in Norway. Acta Neurol Scand Suppl 2007;187:46-50.
31. Pugliatti M, Eskic D, Mikolcić T, et al. Assess, compare and enhance the status of people with MS in Europe: a European Register for Multiple Sclerosis (EUReMS). Acta Neurol Scand 2012;126(Suppl. 195):24-30.
32. Magalhaes S, Wolfson C. Harmonization: a Methodology for Advancing Research in MS. Acta Neurol Scand 2012;126(Suppl. 195):31-35.
33. Andersen O. From the Gothenburg Cohort to the Swedish MS Registry. Acta Neurol Scand 2012;126(Suppl. 195):13-19.
34. Koch-Henriksen N, Stenager E, Laursen B. The use of epidemiological multiple sclerosis registers in research: the Danish MS Registry. Acta Neurol Scand 2012;126(Suppl. 195):7-12.